Alkermes PLC (ALKS) Files 10-K for the Fiscal Year Ended on December 31, 2017

GuruFocus.com
0
In this article:

- By insider

Alkermes PLC (ALKS) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Alkermes PLC is a fully integrated, biopharmaceutical company. It applies its scientific expertise and proprietary technologies to research, develop and commercialize pharmaceutical products to address unmet medical needs of patients. Alkermes PLC has a market cap of $9.82 billion; its shares were traded at around $63.75 with and P/S ratio of 11.59.


For the last quarter Alkermes PLC reported a revenue of $275.4 million, compared with the revenue of $213.5 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $903.4 million, an increase of 21.1% from last year. For the last five years Alkermes PLC had an average revenue growth rate of 15.3% a year.

The reported loss per diluted share was $1.03 for the year, compared with the loss per share of $0.18 in the previous year. The Alkermes PLC had an operating margin of -16.37%, compared with the operating margin of -27.98% a year before. The 10-year historical median operating margin of Alkermes PLC is -18.36%. The profitability rank of the company is 5 (out of 10).

At the end of the fiscal year, Alkermes PLC has the cash and cash equivalents of $590.7 million, compared with $186.4 million in the previous year. The long term debt was $278.4 million, compared with $280.7 million in the previous year. Alkermes PLC has a financial strength rank of 6 (out of 10).

At the current stock price of $63.75, Alkermes PLC is traded at 60.1% premium to its historical median P/S valuation band of $39.82. The P/S ratio of the stock is 11.59, while the historical median P/S ratio is 7.24. The stock gained 12.06% during the past 12 months.

Directors and Officers Recent Trades:

  • President, Alkermes plc Shane Cooke sold 72,793 shares of ALKS stock on 02/02/2018 at the average price of $60.55. The price of the stock has increased by 5.28% since.

  • Director Paul J Mitchell sold 1,000 shares of ALKS stock on 02/01/2018 at the average price of $56.77. The price of the stock has increased by 12.3% since.

  • President, Alkermes plc Shane Cooke sold 5,000 shares of ALKS stock on 01/29/2018 at the average price of $60.01. The price of the stock has increased by 6.23% since.

For the complete 20-year historical financial data of ALKS, click here.

This article first appeared on GuruFocus.


Advertisement

Recommended Stories